文献速递糖尿病

人工智能能否弥合中低收入国家基层糖尿病照护的差距?

Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries?
PubMed 文献 · Lancet Diabetes Endocrinol · 2026-03-24

本文为个人观点文章,探讨人工智能在中低收入国家基层糖尿病照护中的应用机遇与挑战。文章指出AI在糖尿病筛查、风险预测、监测和个性化管理方面有前景,但仍面临基础设施不足、数据碎片化、公平性与包容性、前瞻性验证有限及监管等障碍,并提出未来发展与实施方向。

要点

  • AI在基层糖尿病筛查、风险预测、监测和个性化管理方面显示出前景。
  • 中低收入国家应用AI面临基础设施、数据、公平性、验证和监管等多重障碍。
  • 有效整合需协调投资基础设施、严格验证模型并开展跨学科国际合作。

核心结论

  • AI有潜力改善中低收入国家基层糖尿病照护,但需协调投资基础设施、严格验证和跨学科合作才能从概念验证转为实际应用。

研究设计与样本

  • 本文为个人观点文章,未报告系统检索范围或样本量。

主要发现

  • 新兴证据显示AI在糖尿病及其并发症的筛查、风险预测、监测和个性化管理方面有前景。
  • 中低收入国家应用AI的主要障碍包括基础设施缺陷、数据碎片化、公平与包容性挑战、前瞻性验证有限以及可接受性、可持续性和监管方面的担忧。

临床怎么用

  • AI整合入基层糖尿病照护需大规模开发和严格验证适用于不同人群的AI模型,供基层医生和患者使用。
  • 需开展支持临床、技术和政策领域的跨学科和国际合作以确保成功实施。

局限性

  • 本文为个人观点文章,未提供原始研究数据或系统评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artificial intelligence (AI) has the potential to improve primary diabetes care in low-income and middle-income countries (LMICs), where the rising burden of disease contrasts sharply with limited health-care resources. Emerging evidence shows the promise of AI for screening, risk prediction, monitoring, and personalised management of diabetes and its complications. However, substantial barriers remain, including infrastructure deficits, data fragmentation, equity and inclusivity challenges, limited prospective validation, and concerns about the acceptability, sustainability, and regulatory oversight of AI. The effective integration of AI into primary diabetes care will depend on coordinated investment in foundational infrastructure that includes large-scale development and rigorous validation of novel AI models for use by primary care physicians and patients across diverse populations. AI initiatives are also needed to support interdisciplinary and international collaborations spanning clinical, technical, and policy domains to ensure successful implementation. By aligning technological innovation with health care needs, AI could evolve from a proof-of-concept tool to a practical enabler of equitable, scalable, and cost-effective diabetes care in LMICs. In this Personal View, we outline the major opportunities and challenges of applying AI to primary diabetes care in LMICs, and propose directions for future development and implementation.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Guan Z, Li H, Hernández-Jiménez S, et al. Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries? Lancet Diabetes Endocrinol. 2026. PMID: 41895315. doi:10.1016/S2213-8587(26)00010-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。